跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LORAZE lorazepam 4 mg/1 mL solution for injection ampoule
Approved
STANDARD
LORAZE lorazepam 4 mg/1 mL solution for injection ampoule
Southern XP IP Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e5e0f8276c4dbc04
Company
Southern XP IP Pty Ltd
Type
Standard
Approval Details
Approval Id
e5e0f8276c4dbc04
Product Name
LORAZE lorazepam 4 mg/1 mL solution for injection ampoule
Artg Id
352551
Artg Name
LORAZE lorazepam 4 mg/1 mL solution for injection ampoule
Sponsor
Southern XP IP Pty Ltd
Company Detail Path
/organization/southern-xp-ip-pty-ltd
Artg Date
2022-03-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e5e0f8276c4dbc04
Type
Standard
Back to TGA Approvals
LORAZE lorazepam 4 mg/1 mL solution for injection ampoule - TGA Drug Approval Details
